CE-Iohexol
CE-Iohexol - Study 201
Phase 2 small_molecule terminated
Quick answer
CE-Iohexol for Contrast-induced Nephropathy is a Phase 2 program (small_molecule) at LIGAND PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LIGAND PHARMACEUTICALS INC
- Indication
- Contrast-induced Nephropathy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated